BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research, development, and manufacturing organization (CRDMO) with over 28 years of expertise. Global headquarter in Irvine, California, our global presence spans 7 sites across 6 cities, totaling nearly 3,000 employees. Specializing in small and large molecule discovery, development, scale-up and manufacturing, we offer fully integrated services from target identification to commercial drug product manufacturing.
At BioDuro-Sundia, we leverage our unique technology platforms to support biotech and pharmaceutical partners worldwide. Our comprehensive approach accelerates discovery, de-risks development, and creates higher value outcomes for our clients. Committed to the highest standards of compliance and business operations, we maintain a science-driven, customer-oriented, diversified and people-focused culture.
Dedicated to CRDMO Service business, BioDuro-Sundia operates under one global standard, providing top-tier, integrated, fast, and flexible tailored services to meet the unique needs of our clients and accelerate development timelines.
A portfolio company of Advent International & Bridgewest Group
Advent: leading global private equity, headquartered in Boston
Bridgewest: California-based pharma and life sciences investor
At BioDuro-Sundia, we operate with integrity and strict standards of law and business ethics, which are our fundamental guidelines in all locations. We adhere to the business ethics of legal compliance, integrity, and self-discipline, and always strictly comply with laws and regulations related to corporate governance and the Corporate Governance Code with zero tolerance for any form of corruption. We have built a strong security infrastructure that protects and preserves the intellectual property and data of our customers; We are implementing green manufacturing and sustainable operations across our business units, helping to improve the environment and our communities.
View more
